Physician profile
Scott Sharp
NPI 1518966712
$41,219.45
in general payments reported to CMS, 2019-2025
47 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,994 · 2021: $527 · 2022: $8,881 · 2023: $11K · 2024: $1,945 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,669 · Food and Beverage: $4,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,668.75 |
| Food and Beverage | $4,431.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $32,273.97 | 2019-2025 | Guideliner, Chocolate |
| Boston Scientific Corporation | $2,766.46 | 2019-2025 | Avvigo Guidance System, General - Therapies, Rotapro |
| Abiomed | $636.66 | 2022-2025 | Impella |
| Abbott Laboratories | $494.12 | 2019-2024 | 2nd Gen Centrimag Primary Console, Diamondback Coronary, Jeti All In One Non-Sterile Kit |
| Cardiovascular Systems INC. | $348.69 | 2019-2023 | Diamondback Peripheral |
| Astrazeneca Pharmaceuticals Lp | $332.94 | 2019-2024 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $332.40 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $330.24 | 2019-2024 | Xarelto |
| Pfizer INC. | $277.02 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $259.22 | 2022-2025 | Verquvo |
| Philips North America LLC | $232.40 | 2020-2024 | (6571) Eagle Eye, (Bq9) Coronary Ivus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.23 | 2022-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $201.63 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $196.68 | 2019-2024 | |
| Novo Nordisk INC | $194.94 | 2024-2025 | Wegovy, Ozempic |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $183.14 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $169.25 | 2019-2025 | Evkeeza |
| Amgen INC. | $154.66 | 2019-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $136.07 | 2019-2020 | |
| Heartflow, INC. | $115.48 | 2023 | Ffrct |
| Kiniksa Pharmaceuticals International, Plc | $108.62 | 2024 | Arcalyst |
| Livanova USA, INC. | $105.49 | 2020 | |
| Vifor Pharma, INC. | $99.75 | 2019-2020 | |
| Altathera Pharmaceuticals LLC | $91.76 | 2022-2023 | Sotalol Hydrochloride |
| Arrow International, INC. | $77.33 | 2022 | |
| Penumbra, INC. | $76.27 | 2019-2025 | Penumbra System |
| Terumo Medical Corporation | $74.62 | 2019-2022 | |
| Stryker Corporation | $74.15 | 2025 | Flowtriever |
| Mindray Ds USA, INC. | $65.74 | 2021 | |
| Ekos Corporation | $53.42 | 2019 | |
| Edwards Lifesciences Corporation | $52.76 | 2024-2025 | Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $51.07 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $50.72 | 2023-2025 | Camzyos, Eliquis |
| Lantheus Medical Imaging, INC. | $49.69 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $41.53 | 2024 | Onpattro |
| Angiodynamics, INC. | $38.58 | 2020-2023 | Soft-Vu |
| Kowa Pharmaceuticals America, INC. | $35.19 | 2019-2020 | |
| Biotronik INC. | $31.32 | 2021-2024 | Nhancer Rx, Recross |
| Daiichi Sankyo INC. | $28.44 | 2023 | Injectafer |
| Chiesi USA, INC. | $27.15 | 2024-2025 | Kengreal, Cleviprex |
| Lexicon Pharmaceuticals, INC. | $26.36 | 2024 | |
| Integra Lifesciences Corporation | $24.15 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Atricure, INC. | $23.15 | 2025 | Synergy Ablation System |
| Bridgebio Pharma, INC. | $20.03 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, Ltd. | $19.71 | 2023 | Arcalyst |
| Medtronic, INC. | $17.03 | 2024 | Linq II |
| Kestra Medical Technology Services, INC. | $15.22 | 2023 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.